212 related articles for article (PubMed ID: 15679420)
1. Estrogen receptor expression in papillary urothelial carcinoma of the bladder and ovarian transitional cell carcinoma.
Croft PR; Lathrop SL; Feddersen RM; Joste NE
Arch Pathol Lab Med; 2005 Feb; 129(2):194-9. PubMed ID: 15679420
[TBL] [Abstract][Full Text] [Related]
2. Short telomeres and chromosome instability prior to histologic malignant progression and cytogenetic aneuploidy in papillary urothelial neoplasms.
Izumiyama-Shimomura N; Nakamura K; Aida J; Ishikawa N; Kuroiwa M; Hiraishi N; Fujiwara M; Ishikawa Y; Inoshita N; Yonese J; Matsuura M; Poon SS; Arai T; Takubo K
Urol Oncol; 2014 Feb; 32(2):135-45. PubMed ID: 23510865
[TBL] [Abstract][Full Text] [Related]
3. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma.
Sun W; Herrera GA
Hum Pathol; 2002 Oct; 33(10):996-1000. PubMed ID: 12395372
[TBL] [Abstract][Full Text] [Related]
5. Transitional cell carcinomas of the ovary and bladder are immunophenotypically different.
Ordóñez NG
Histopathology; 2000 May; 36(5):433-8. PubMed ID: 10792484
[TBL] [Abstract][Full Text] [Related]
6. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
Amara N; Palapattu GS; Schrage M; Gu Z; Thomas GV; Dorey F; Said J; Reiter RE
Cancer Res; 2001 Jun; 61(12):4660-5. PubMed ID: 11406532
[TBL] [Abstract][Full Text] [Related]
7. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
[TBL] [Abstract][Full Text] [Related]
8. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.
Zhang ZT; Pak J; Shapiro E; Sun TT; Wu XR
Cancer Res; 1999 Jul; 59(14):3512-7. PubMed ID: 10416618
[TBL] [Abstract][Full Text] [Related]
9. The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma.
Keck B; Stoehr R; Wach S; Rogler A; Hofstaedter F; Lehmann J; Montironi R; Sibonye M; Fritsche HM; Lopez-Beltran A; Epstein JI; Wullich B; Hartmann A
Int J Cancer; 2011 Jul; 129(2):346-54. PubMed ID: 20878954
[TBL] [Abstract][Full Text] [Related]
10. Frequent FGFR3 mutations in urothelial papilloma.
van Rhijn BW; Montironi R; Zwarthoff EC; Jöbsis AC; van der Kwast TH
J Pathol; 2002 Oct; 198(2):245-51. PubMed ID: 12237885
[TBL] [Abstract][Full Text] [Related]
11. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
Oliva E; Amin MB; Jimenez R; Young RH
Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive Papillary Urothelial Carcinoma of the Bladder: An Institutional Experience Focusing on Tumors With Borderline Features.
Oliver-Krasinski JM; Bidot S; Ingram JW; O'Toole KM; McKiernan JM; Tinsley M; Harik LR
Arch Pathol Lab Med; 2024 Feb; 148(2):223-229. PubMed ID: 37134243
[TBL] [Abstract][Full Text] [Related]
13. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
14. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.
Lazzeri M; Vannucchi MG; Spinelli M; Bizzoco E; Beneforti P; Turini D; Faussone-Pellegrini MS
Eur Urol; 2005 Oct; 48(4):691-8. PubMed ID: 15992990
[TBL] [Abstract][Full Text] [Related]
15. p53 protein and Ki-67 overexpression in urothelial dysplasia of bladder.
Sun W; Zhang PL; Herrera GA
Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):327-31. PubMed ID: 12607601
[TBL] [Abstract][Full Text] [Related]
16. Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression.
Lawless M; Gulati R; Tretiakova M
Histopathology; 2017 Sep; 71(3):406-414. PubMed ID: 28470753
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer.
Boorjian S; Ugras S; Mongan NP; Gudas LJ; You X; Tickoo SK; Scherr DS
Urology; 2004 Aug; 64(2):383-8. PubMed ID: 15302512
[TBL] [Abstract][Full Text] [Related]
18. Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder.
Lee H; Jun SY; Lee YS; Lee HJ; Lee WS; Park CS
Virchows Arch; 2014 Feb; 464(2):213-20. PubMed ID: 24306957
[TBL] [Abstract][Full Text] [Related]
19. Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases.
Fox MD; Xiao L; Zhang M; Kamat AM; Siefker-Radtke A; Zhang L; Dinney CP; Czerniak B; Guo CC
Am J Clin Pathol; 2017 May; 147(5):500-506. PubMed ID: 28371875
[TBL] [Abstract][Full Text] [Related]
20. Keratin 17 is a sensitive and specific biomarker of urothelial neoplasia.
Babu S; Mockler DC; Roa-Peña L; Szygalowicz A; Kim NW; Jahanfard S; Gholami SS; Moffitt R; Fitzgerald JP; Escobar-Hoyos LF; Shroyer KR
Mod Pathol; 2019 May; 32(5):717-724. PubMed ID: 30443013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]